Open AccessAssessment of Post Vaccination Symptoms Following COVID-19 Vaccination in India: A Cross-Sectional Descriptive Study
Author(s) -
Deshpande Sanjay,
Patil Suvarna,
Ninad Nagrale,
Swarupa Chakole
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i58b34219
Subject(s) - myalgia , medicine , vaccination , cross sectional study , pandemic , covid-19 , environmental health , pediatrics , family medicine , disease , virology , pathology , infectious disease (medical specialty)
The recent examples of newly emerged diseases that causes alarming situation globally include H1N1, Congo Hemorrhagic fever, Ebola virus diseases, Nipah Virus Infection, Lassa Fever and newly declared global emergency pandemic SARS nCOVID-19 infection. Since its emergence, it has spread around the globe. It tends to spread by the inhalation of the respiratory aerosols, direct human contact.
Materials and Methods: This analytical study was carried out among the healthcare workers and people who received either of Covishield or Covaxin. The online survey questionnaire was prepared and data obtained through the responses to the survey proforma.
Results: 86.17% respondents were above 40 years, 69.15% males and 30.85% were females. 89.36% were vaccinated with Covishield and 10.64% by Covaxin. 75.53% respondents experienced post vaccination symptoms; commonest were the local pain at injection site (28.72%), fever (12.76%), Myalgia (12.77%). The symptoms were found more in respondents with any of co-morbid condition.
Discussion: Covishield was used more commonly than Covaxin in study samples. The symptoms following vaccination were more common in 40-60 age group and persons with co-morbid conditions.